Maze Therapeutics, Inc. financial data

Symbol
MAZE on Nasdaq
Location
171 Oyster Point Boulevard, Suite 300, South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.43K %
Debt-to-equity 27 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.1M shares
Common Stock, Shares, Outstanding 48.1M shares
Common Stock, Value, Issued 48K USD
Weighted Average Number of Shares Outstanding, Basic 45.8M shares +1795%
Weighted Average Number of Shares Outstanding, Diluted 45.8M shares +1795%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 25.2M USD +26.9%
General and Administrative Expense 7.78M USD +13.1%
Operating Income (Loss) -33M USD -36.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30.1M USD -20.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -30.1M USD -21.6%
Earnings Per Share, Basic -0.66 USD/shares +93.6%
Earnings Per Share, Diluted -0.66 USD/shares +93.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 317M USD +112%
Marketable Securities, Current 67.2M USD
Cash, Cash Equivalents, and Short-term Investments 384M USD
Assets, Current 391M USD
Property, Plant and Equipment, Net 5.54M USD
Operating Lease, Right-of-Use Asset 20.9M USD
Other Assets, Noncurrent 3.21M USD
Assets 422M USD
Accounts Payable, Current 2.92M USD
Employee-related Liabilities, Current 8.19M USD
Liabilities, Current 22.1M USD
Operating Lease, Liability, Noncurrent 19.4M USD
Other Liabilities, Noncurrent 1.09M USD
Liabilities 42.6M USD
Retained Earnings (Accumulated Deficit) -455M USD
Stockholders' Equity Attributable to Parent 379M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 379M USD
Liabilities and Equity 422M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.5M USD -25.9%
Net Cash Provided by (Used in) Financing Activities 127M USD +418%
Net Cash Provided by (Used in) Investing Activities -299K USD -7.17%
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 48.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 318M USD +111%
Depreciation 684K USD -28%
Payments to Acquire Property, Plant, and Equipment 299K USD +7.17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30M USD -21.3%
Operating Lease, Liability, Current 4.76M USD
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 834M USD
Share-based Payment Arrangement, Expense 3.86M USD +64.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares